CpG-containing ODN has a limited role in the protection against Toxoplasma gondii


Por: Saavedra R., Leyva R., Tenorio E.P., Haces M.L., Rodríguez-Sosa M., Terrazas L.I., Hérion P.

Publicada: 1 ene 2004
Resumen:
Bacterial DNA containing immunostimulatory motifs (CpG) induces the development of a TH1 immune response. Since protection against Toxoplasma gondii is correlated with this type of response, the aim of this work was to determine if a synthetic oligodeoxynucleotide (ODN) containing CpG sequences could be useful as adjuvant for the induction of a long-lasting protective immune response against T. gondii. BALB/c mice immunized with a total soluble antigen of T. gondii (TSA2) mixed with ODN-containing CpG sequences developed a typical TH1 response, as determined by antibody isotypes and interferon-? (IFN-?) and interleukin-4 (IL-4) production by spleen cells. However, they did not resist a challenge with the virulent RH strain of the parasite. Absence of protection paralleled with lower levels of IFN-?, when compared with mice vaccinated with the live tachyzoites of the attenuated ts.4 strain of the parasite, which resisted this challenge. Intraperitoneal injection of ODN alone to mice induced a high degree of resistance to a lethal challenge inoculated by the same route. Nevertheless, this nonspecific protection was transient. Thus, the use of ODN containing CpG motifs as adjuvant is of limited value for the induction of a protective immune response against T. gondii.

Filiaciones:
Saavedra R.:
 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Mexico City, Mexico

 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Ap. Postal 70228, C.U., CP 04510, México D.F., Mexico

Leyva R.:
 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Mexico City, Mexico

Tenorio E.P.:
 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Mexico City, Mexico

Haces M.L.:
 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Mexico City, Mexico

 Departamento de Neurociencias, Inst. de Fisiología Celular, Univ. Nac. Auton. de México, Mexico City, Mexico

Rodríguez-Sosa M.:
 Unidad de Biomedicina, FES Iztacala, Univ. Nac. Auton. de México, Mexico City, Mexico

Terrazas L.I.:
 Unidad de Biomedicina, FES Iztacala, Univ. Nac. Auton. de México, Mexico City, Mexico

Hérion P.:
 Departamento de Inmunología, Inst. de Invest. Biomédicas, Univ. Nac. Auton. de México, Mexico City, Mexico
ISSN: 01419838
Editorial
Blackwell Publishing Ltd, 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 26 Número: 2
Páginas: 67-73
WOS Id: 000222286000002
ID de PubMed: 15225293

MÉTRICAS